Literature DB >> 25564161

Presence of Concomitant Non-muscle-invasive Bladder Cancer in Chinese Patients with Upper Tract Urothelial Carcinoma: Risk Factors, Characteristics, and Predictive Value.

Dong Fang1, Lei Zhang, Xuesong Li, Wei Yu, Nirmish Singla, Guangzhi Zhao, Gengyan Xiong, Yi Song, Qun He, Zhisong He, Liqun Zhou.   

Abstract

PURPOSE: To explore the characteristics, predictive risk factors, and prognostic effect of concomitant non-muscle-invasive bladder cancer (NMIBC) in patients with upper tract urothelial carcinoma (UTUC).
METHODS: We evaluated 727 consecutive UTUC patients treated with radical resection between 2000 and 2012 in a high-volume center of China. Preoperative cystoscopy was performed in all patients. Patients with previous or concomitant total cystectomy were excluded.
RESULTS: Overall, 73 patients (10.0 %) had NMIBC. Concomitant NMIBC was associated with previous bladder cancer (p = 0.003), tumor located in ureter (p = 0.008), multifocality (p < 0.001), and preoperative renal insufficiency (p = 0.023). The presence of concomitant NMIBC was predictive for lower tumor stage (p = 0.019), papillary architecture (p = 0.023), and organ-confined disease (pT < 3 and N-, p = 0.006). The median follow-up duration was 57 months. The presence of concomitant NMIBC was a risk factor for bladder recurrence (p < 0.001), and particularly in patients with non-muscle-invasive UTUCs, it affects cancer-specific survival (odds ratio 1.614, p = 0.030) and contralateral recurrence (odds ratio, 1.907, p = 0.016). Most concomitant NMIBC were found at the lateral wall or bladder neck, while most intravesical recurrences occurred near the site of surgery or posterior wall.
CONCLUSIONS: The most common site for concomitant NMIBC was lateral wall and bladder neck, and previous bladder cancer, tumor located in ureter, tumor multifocality, and preoperative renal insufficiency were risk factors for concomitant NMIBC. The presence of concomitant NMIBC is predictive for relative better pathologic outcomes but higher rate of bladder recurrence, while the effect on postoperative survival was limited with patients early-stage UTUCs. The potential mechanisms need further investigation.

Entities:  

Mesh:

Year:  2015        PMID: 25564161     DOI: 10.1245/s10434-014-4302-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

Review 1.  Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.

Authors:  Aurélie Mbeutcha; Morgan Rouprêt; Ashish M Kamat; Pierre I Karakiewicz; Nathan Lawrentschuk; Giacomo Novara; Jay D Raman; Christian Seitz; Evanguelos Xylinas; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-04-21       Impact factor: 4.226

2.  Characteristics and treatment outcomes of pan-urothelial cell carcinoma: a descriptive analysis of 45 patients.

Authors:  Dong Fang; Pei Liu; Xuesong Li; Gengyan Xiong; Lei Zhang; Nirmish Singla; Guangzhi Zhao; Qun He; Zhisong He; Liqun Zhou
Journal:  Sci Rep       Date:  2015-12-10       Impact factor: 4.379

Review 3.  Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature.

Authors:  Aurélie Mbeutcha; Romain Mathieu; Morgan Rouprêt; Kilian M Gust; Alberto Briganti; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Transl Androl Urol       Date:  2016-10

4.  Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.

Authors:  Xiaoying Li; Ming Cui; Xiaobin Gu; Dong Fang; Hongzhen Li; Shangbin Qin; Kunlin Yang; Tianzhao Zhu; Xuesong Li; Liqun Zhou; Xian-Shu Gao; Dian Wang
Journal:  World J Surg Oncol       Date:  2020-05-30       Impact factor: 2.754

5.  Predictive Value of Preoperative Positive Urine Cytology for Development of Bladder Cancer After Nephroureterectomy in Patients With Upper Urinary Tract Urothelial Carcinoma: A Prognostic Nomogram Based on a Retrospective Multicenter Cohort Study and Systematic Meta-Analysis.

Authors:  Bo Fan; Yuanbin Huang; Shuang Wen; Qiliang Teng; Xinrui Yang; Man Sun; Tingyu Chen; Yan Huang; Yumei Wang; Zhiyu Liu
Journal:  Front Oncol       Date:  2021-10-01       Impact factor: 6.244

6.  MicroRNA-143-3p/TBX3 Axis Represses Malignant Cell Behaviors in Bladder Cancer.

Authors:  Lifu Huang; Xianjun Zhang; Feiping Li; Xiaohong Wang
Journal:  Comput Math Methods Med       Date:  2022-01-27       Impact factor: 2.238

7.  The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma.

Authors:  Teruo Inamoto; Hideyasu Matsuyama; Shigeru Sakano; Naokazu Ibuki; Kiyoshi Takahara; Kazumasa Komura; Tomoaki Takai; Takuya Tsujino; Yuki Yoshikawa; Koichiro Minami; Kazuhiro Nagao; Ryo Inoue; Haruhito Azuma
Journal:  Oncotarget       Date:  2017-11-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.